JP2009511516A5 - - Google Patents

Download PDF

Info

Publication number
JP2009511516A5
JP2009511516A5 JP2008534894A JP2008534894A JP2009511516A5 JP 2009511516 A5 JP2009511516 A5 JP 2009511516A5 JP 2008534894 A JP2008534894 A JP 2008534894A JP 2008534894 A JP2008534894 A JP 2008534894A JP 2009511516 A5 JP2009511516 A5 JP 2009511516A5
Authority
JP
Japan
Prior art keywords
ylmethyl
aminopyridin
alkylene
propionic acid
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008534894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009511516A (ja
JP5266053B2 (ja
Filing date
Publication date
Priority claimed from DE102005049385A external-priority patent/DE102005049385A1/de
Application filed filed Critical
Publication of JP2009511516A publication Critical patent/JP2009511516A/ja
Publication of JP2009511516A5 publication Critical patent/JP2009511516A5/ja
Application granted granted Critical
Publication of JP5266053B2 publication Critical patent/JP5266053B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008534894A 2005-10-15 2006-09-30 TAFIaのインヒビターとしてのイミダゾール誘導体 Expired - Fee Related JP5266053B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005049385.8 2005-10-15
DE102005049385A DE102005049385A1 (de) 2005-10-15 2005-10-15 Imidazolderivate als Inhibitoren von TAFIa
PCT/EP2006/009500 WO2007045339A1 (de) 2005-10-15 2006-09-30 Imidazolderivate als inhibitoren von tafi-a

Publications (3)

Publication Number Publication Date
JP2009511516A JP2009511516A (ja) 2009-03-19
JP2009511516A5 true JP2009511516A5 (https=) 2009-11-19
JP5266053B2 JP5266053B2 (ja) 2013-08-21

Family

ID=37733974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008534894A Expired - Fee Related JP5266053B2 (ja) 2005-10-15 2006-09-30 TAFIaのインヒビターとしてのイミダゾール誘導体

Country Status (12)

Country Link
US (1) US8044208B2 (https=)
EP (1) EP1937673B1 (https=)
JP (1) JP5266053B2 (https=)
CY (1) CY1117379T1 (https=)
DE (1) DE102005049385A1 (https=)
DK (1) DK1937673T3 (https=)
ES (1) ES2558874T3 (https=)
HU (1) HUE026577T2 (https=)
PL (1) PL1937673T3 (https=)
PT (1) PT1937673E (https=)
SI (1) SI1937673T1 (https=)
WO (1) WO2007045339A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009103432A2 (en) * 2008-02-21 2009-08-27 Sanofi-Aventis Covalently binding imaging probes
NZ592764A (en) * 2008-10-29 2012-08-31 Taisho Pharmaceutical Co Ltd Compound having tafia inhibitory activity
DK2548871T3 (da) 2010-03-18 2017-11-06 Daiichi Sankyo Co Ltd Cycloalkylsubstitueret imidazolderivat
KR20130006620A (ko) * 2010-03-18 2013-01-17 다이이찌 산쿄 가부시키가이샤 시클로프로판카르복실산 유도체
KR101799429B1 (ko) 2010-05-03 2017-11-21 에스케이바이오팜 주식회사 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
CA2914533A1 (en) 2013-06-10 2014-12-18 Sanofi Macrocyclic urea derivatives as inhibitors of tafia, their preparation and their use as pharmaceuticals
AU2020407664A1 (en) 2019-12-20 2022-08-18 Tenaya Therapeutics, Inc. Fluoroalkyl-oxadiazoles and uses thereof
AU2022270657A1 (en) 2021-05-04 2023-11-16 Tenaya Therapeutics, Inc. 2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL361054A1 (en) * 2000-08-17 2004-09-20 Pfizer Inc. Substituted imidazoles as tafia inhibitors
WO2003013526A1 (en) * 2001-08-08 2003-02-20 Merck & Co. Inc. Anticoagulant compounds
WO2003061653A1 (en) * 2002-01-22 2003-07-31 Pfizer Limited 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases

Similar Documents

Publication Publication Date Title
ES2665036T3 (es) Bencilinazoles sustituidos para su uso como inhibidores de BUB1 cinasa en el tratamiento de enfermedades hiperproliferativas
CA2346396C (en) 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
ES2276803T3 (es) Inhibidores de polimerasa viral.
ES2246240T3 (es) Bencimidazoles sustituidos.
JP2009511516A5 (https=)
CN115894463A (zh) 一种rock抑制剂的制备方法、其中间体及中间体的制备方法
WO2011088192A1 (en) Compounds and methods
ES2782509T3 (es) Procedimiento para la preparación de 1,2,4-oxadiazoles 3,5-disustituidos
HRP20120379T1 (hr) Triheterociklički spojevi, pripravci i postupci za liječenje karcinoma
AU2005210004A1 (en) Novel inhibitors of glutaminyl cyclase
BRPI1008498B1 (pt) Compostos de piridazinona úteis como inibidores da fosfodiesterase 10a, composição farmacêutica, e, uso de um composto
SK9062003A3 (en) Substituted triazole diamine derivatives as kinase inhibitors
CN104024250B (zh) 作为痕量胺相关受体(taar)的杂环衍生物
WO1999052525A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos
RU2303032C2 (ru) Замещенные дикетопиперазины как антагонисты окситоцина
JP2010503625A5 (https=)
CN101987848A (zh) 新的二氢吲哚酮化合物、它们的制备方法以及包含它们的药物组合物
Tran et al. In vitro and in silico determination of glutaminyl cyclase inhibitors
JP2011521981A5 (https=)
RU2010122320A (ru) Новые производные 1, 3-дигидро-5-изобензофуранкарбонитрила и фармацевтическая композиция на их основе для лечения преждевременной эякуляции
AU2016362394A1 (en) Heterocycle compounds and uses thereof
TW201339153A (zh) 包含hcv ns5a之抑制劑的固體形式、其組合物及其用途
JP2010519278A5 (https=)
CN101796043A (zh) 苯并呋喃-和苯并[b]噻吩-2-羧酸酰胺衍生物及其作为阻胺3受体调节剂的应用
SK11422001A3 (sk) Heteroarylamidíny, metylamidíny a guanidíny ako inhibítory proteázy